High Level Serum Procalcitonin Associated Gouty Arthritis Susceptibility: From a Southern Chinese Han Population

Wen Liu1, Keshav Raj Sigdel2, Ying Wang1

  • 1Department of Rheumatology and Clinical Immunology, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China.

Plos One
|July 17, 2015
PubMed

Insights

Serum Procalcitonin (PCT) levels are elevated in inflammatory arthritis, particularly gouty arthritis. This suggests PCT may serve as an indicator beyond infection, aiding in gouty arthritis diagnosis.

Area of Science:

  • Rheumatology and Immunology
  • Clinical Biochemistry

Background:

  • Procalcitonin (PCT) is typically used as a biomarker for bacterial infections.
  • Its role in non-infectious inflammatory conditions like arthritis is less understood.

Purpose of the Study:

  • To investigate serum PCT levels in patients with gouty arthritis (GA), rheumatoid arthritis (RA), and ankylosing spondylitis (AS) without infection.
  • To explore the potential of PCT to differentiate gouty arthritis.

Main Methods:

  • Serum PCT levels were measured using electrochemiluminescence immunoassay (ECLIA) in 51 GA, 37 RA, 41 AS patients, and 33 healthy controls.
  • Disease activity was assessed using VAS, DAS28, and ASDAS scores. Other parameters included CRP, ESR, and WBC.

Main Results:

  • Serum PCT levels were significantly higher in GA patients compared to RA and AS patients, especially those with tophi.
  • PCT showed positive correlations with disease activity markers (VAS, CRP, ESR) in GA.
  • Correlations were also observed in RA and AS, but without significant differences.

Conclusions:

  • Serum PCT is not exclusively a marker for infection.
  • PCT may serve as a valuable indicator in inflammatory arthritis, with particular relevance for gouty arthritis.
Abstract